The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“certain treatment suggestions that evolved during this period [76], such as garlic, malaria, and hydroxychloroquine”
From Psychosocial Effects of the COVID-19 Pandemic: Large-scale Quasi-Experimental Study on Social Media (2020) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731
Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651
Self-citationIn vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644
New insights into the antiviral effects of chloroquine
Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471
Self-citationRolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408
Self-citation
Cited by
Sorted by citations
Items 801–900 of 937
Basta, D., & Latinovic, O. S. (2020) · Journal of Clinical and Laboratory Medicine · doi:10.16966/2572-9578.135
Remdesivir in treating coronavirus- A review
Hassan, S. A., Bhateja, S., Arora, G., & Prathyusha, F. (2020) · IP International Journal of Periodontology and Implantology · doi:10.18231/j.ijpi.2020.013
Case of COVID-19 Pneumonia: Lessons Learnt
Tay, N. C., & Chua, A. H. L. (2020) · The Singapore Family Physician · doi:10.33591/sfp.46.4.uc2
Ciepłucha, H. D., & Knysz, B. (2020) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.3589
How to Run the Cardiology Service in COVID Times? A Practical Guide
Kapil, A., & Ramakrishnan, S. (2020) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_48_20
Pharmacogenomics to Drive COVID-19 Therapy for Best Outcome in a Low Resource SettingPreprint
Iyer, G. R., Zubeda, S., Kamireddy, A. P., & Hasan, Q. A. (2020) · doi:10.21467/preprints.214
Al-Janabi, W., & Abras, A. (2020) · doi:10.35456/usajmr001001004
Chloroquine and Hydroxychloroquine in Treatment of Coronavirus Disease-19
Poposka, L., & Mitevska, I. P. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4895
Hoda, F., Verma, R., Rastogi, S., Iqubal, A., Haque, S. E., Akhtar, M., & Najmi, A. K. (2020) · Coronaviruses · doi:10.2174/2666796701999201014160857
Overview of SARS-CoV-2 Outbreak and Potential Therapeutic Strategies
Eldalal, O., Oyebanji, O. A., Thapa, P., & Oroszi, T. L. (2020) · Global Journal of Health Science · doi:10.5539/gjhs.v12n13p95
Are herbal drugs effective in COVID management? A review to demystify the current facts and claimsPreprint
Beg, M. R., Siddiqui, B., Waghmare, P., Ghodinde, S., & Bikkad, S. (2020) · doi:10.14293/s2199-1006.1.sor-.ppxfif7.v2
Marins, G. D. O., Cardoso, N. M. A., Miranda, M. M. M., Soares, L. R., & de Almeida, K. C. L. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.09
Intercorrências obstétricas e neonatais: Complicações que acomentem o recém nascido
Machado, A. T., Zemolin, C. M., Dias, C. F. C., da Silva, E., Diniz, C. A. E. S., & Diaz, C. M. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.07
de Andrade, C. C. N., Batista, L. M., & de Macêdo, L. L. A. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.18
Rocha, A. D. S., Gomes, B. M. G., Sousa, R. M., Morais, A. S. D. R., Batista, M. A. S., & Gonçalves, R. C. M. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.06
Garcia, A. P. S., Teles, B. D. C., Fouchy, B. V., Soares, C. M., Hall, K. C., & Pataca, J. D. C. C. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.19
Prevenindo quedas domésticas dos idosos através de estratégias educativas em saúde
Rocha, J. R. B., Neto, G. T., da Silva, M. M., Pereira, T. M. R., Silva, J. M., & de Sousa, R. S. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.13
da Silva, R., Nascimento, L. C., & de Albuquerque, A. M. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.01
Silva, M. D. S., de Santana, F. M., Barboza, J. A., de Pádua, E. L., Dantas, E. M. V., & Melo, E. D. S. C. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.11
Cuidados paliativos, assistência domiciliar e a concepção dos cuidadores: Revisão Integrativa
de Santana, L. M. G., Ribeiro, S. M. S., dos Santos, G. M. R. F., Belmonte, B. D. R., & da Silva, M. E. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.03
Desafios na inclusão social de surdos no contexto da saúde
de Oliveira, L. G. A., & de Abrantes, M. J. G. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.16
A educação hídrica em um encontro com idosos
Borges, B. E. C., Medeiros, M. R. D. S., Távora, R. C. D. O., & Lima, N. M. F. V. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.14
Khodashahi, R., Naderi, H., Bojdy, A., & Khodashahi, M. (2020) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x16999201202121247
Hydroxychloroquine in fighting COVID-19: What led WHO to suspend clinical trial of drug
Pacheco, T. J. A., de Souza, D. G., Faria, R. S., & de Andrade, L. R. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.21
Assis, M. G., Cirne, D. D. S. J., Ferreira, K. W. D. L., de Oliveira, R. S. S., & Cabral, L. A. C. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.12
A atuação da enfermagem na Atenção Primária frente a disfunção sexual no pós-parto
Fonseca, A. L. D. S., Guedes, E. M., Irineu, M. E. D. S., & do Nascimento, C. P. A. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.04
Advances in treatment of COVID-19
Wu, Q., Xu, Y., Peng, W., Feng, F., Wang, Z., Han, D., Gu, C., & Zhou, X. (2020) · Integrative Respiratory Medicine · doi:10.1051/irm/2020001
Dogra, P., Sharma, B., Sharma, S., & Sharma, R. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20205773
The Pathophysiology of Repurposed Antiviral Drugs for treatment of COVID-19 Infection
Haider, A., Faheem, M. Q., Jamal, S. B., Naeem, M., Khalil, A. A. K., Khan, R., & Subhan, F. (2020) · Life and Science · doi:10.37185/lns.1.1.155
Viana, N. I., Pimenta, R., Gonçalves, G. L., Gomes, T. F., Guimarães, V. R., Sro, V., Sro, M., Leite, K. R. M., & Reis, S. T. (2020) · doi:10.21203/rs.3.rs-33160/v1
Treatment of COVID19 with antimalarial medicines: clinical pharmacology analysis
Колбин, А. С. (2020) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2020.3.164-174
“COVID-19 – Current Status and Trends: A Comprehensive Review
Mathew, C. (2021) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v15i1.13533
Hydroxychloroquine: the story of one drug during the COVID-19 pandemic
Nikonov, E. L., Zhuravleva, M. V., Zharova, M. E., & Gorelov, M. V. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20202308174
Translational research in drug discovery: Tiny steps before the giant leap
Upadrasta, S., & Yadav, V. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821972-0.00010-1
BUTROUS, G. S. (2020) · Interdisciplinary Approaches to Medicine · doi:10.26577/iam.2020.v1.i2.01
Drug repurposing in the treatment of COVID-19: A review
Sonali, S., Vikrant, L. S., & Madhuri, D. (2021) · Research in Pharmacy · doi:10.25081/rip.2021.v11.6611
Abdallat, Y. (2021) · Studies in systems, decision and control · doi:10.1007/978-3-030-67151-8_14
Potential Adverse Effects of Coronavirus Disease 2019 on the Cardiovascular System
Wang, B.-Y., You, B., & Liu, F. (2021) · Cardiology Plus · doi:10.4103/2470-7511.312592
I. Cloroquina / hidroxicloroquina y azitromicina. Revisión narrativa de seguridad
Comoglio, R. H. (2020) · Latin American Journal of Clinical Sciences and Medical Technology · doi:10.34141/ljcs2866115
Coronavirus (COVID-19): A new pandemic
Regulatory Affairs Officer, I. C. L., Kumar, V., Priyadarshinee, S., & Naik, S. (2020) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2020.0007
Fantini, J. (2021) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_54
López, J.-G., Barbosa, J. C. C., Felipe-Díaz, O. J., Rojas-Zuleta, W. G., Ballesteros, J.-G., Navarro-Mendoza, E., Herrera, C.-L. G., Giraldo, R. B., Padilla-Tovar, L., Duque-Zapata, N., et al. (2021) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2020.05.009
REPOSICIONAMENTO DE MEDICAMENTOS COMO ALTERNATIVA TERAPÊUTICA NO TRATAMENTO DA COVID-19
de Siqueira, E. C., de França, J. A. A., & de Siqueira, R. C. (2021) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-88958-29-2/53-65
Rabbani, S. A., Sharma, S., Mishra, S., & Mahtab, A. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i24b31445
Identifying Side Effects of Some Drugs Used in Covid-19 TreatmentPreprint
Aygün, İ., Kaya, M., & Alhajj, R. (2020) · doi:10.21203/rs.3.rs-40903/v1
A Systematic Review on Various Therapeutic Options for Coronavirus Outbreak
Khan, S. R., Sharma, B., & Bhattacharya, S. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i2-s.4650
Araç, S., KARAHAN, M. Z., Özel, M., YİĞİT, R., Akkoç, H., & Araç, E. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.843042
Hydroxychloroquine and Azithromycin Use in COVID-19 Era and Cardiovascular Concerns
Kapoor, A., & Sahu, A. K. (2021) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_85_20
COVID-19 Global Pandemic Fight by Drugs: A Mini-Review on Hope and Hype
Tekale, S. U., Gore, V., Kendrekar, P. S., Thore, S. N., Kótai, L., & Pawar, R. (2021) · Mini-Reviews in Organic Chemistry · doi:10.2174/1570193x18666210629103117
Borsukov, A. V., Morozova, T. G., Venidiktova, D. Y., Витальевна, Т. А., Gorbatenko, O. А., Kovalyov, А. A., Tagil, A. O., Eryomkina, A. V., & Bezmenova, T. S. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-13-31-35
Firdaus, Z., Singh, S. K., Singh, T. D., & Singh, M. (2021) · European Journal of Chemistry · doi:10.5155/eurjchem.12.2.222-234.2084
Novel Corona Virus Disease 2019 (Review on nCOVID-19)Preprint
Shahzad, M. M., Hussain, S., Rehman, R. A., Hussain, Z., Bashir, S., Khalid, F., Rafique, T., Akhtar, K., Tahir, L., Hussain, M., et al. (2020) · doi:10.22541/au.159183168.85743189
de Araújo, F. E. A., da Rocha, J. M. C., Marques, L. E. R. D. M., Macêdo, K. L. D. S., Melo, P. K. M., Duarte, G. M., Pinheiro, F. I., & Gúzen, F. P. (2019) · International Journal of Engineering & Technology · doi:10.14419/ijet.v7i4.17193
Infection au nouveau coronavirus chez un professionnel de la santé suite à un accès palustre
Cissé, I. M., Alassani, A. C., Adjobimey, M., Mikponhoué, R., Hinsou, A., Attinsounon, C. A., & Al, E. (2021) · Revue Malienne d Infectiologie et de Microbiologie · doi:10.53597/remim.v16i1.1769
Development of research on COVID-19 by the World Scientific CommunityPreprint
co, D. T., & Borschiver, S. (2020) · doi:10.22541/au.159586093.37489192
Nessaibia, I., Tichati, L., Bouarroudj, T., Dafne, S., Bouslama, Z., Merad, T., & Tahraoui, A. (2021) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2021.07.003
Ennibi, K., Kasmy, Z., Reggad, A., Laatiris, A., Youssef, A. A. D. I., Nachite, A., Maatalaoui, F., Roufik, I., El Amraoui, F., Sefsafi, Y., et al. (2021) · Journal of Bacteriology and Mycology · doi:10.26420/jbacteriolmycol.2021.1174
Promising Enzymes for Inhibitors Development Against COVID-19
Sun, Z., Yu, F., Qiu, X., Li, S., Li, X.-T., & Zhu, H. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210805104250
Desenvolvimento de Novas Tecnologias Baseadas em Materiais Biocidas
de Assis, M. (2021) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14104.2021.793638
Research Status of Aerosol Inhalation Drugs in COVID-19 Outbreak
秦, 浩. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.118508
COVID-19 and the Challenges it Poses are Discussed
ALjohni, A. R. S. (2021) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2021.04.0909
COVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTIMALARIALS AND ANTIPARASITIC DRUGS USED
Guedes, I. H. L., dos Santos, G. D., Viana, A. B. F., Araújo, G. D. S., dos Santos, T. C. P., Moreno, C. J. G., & Donato, S. T. (2021) · Health and Society · doi:10.51249/hes01.04.2021.453
SARS-CoV-2: REALITY AND CHALLENGES IN TREATMENT AND VACCINE DEVELOPMENT, WHERE DO WE STAND?
Malaysia, U. S., Subramaniam, N., Mat, N. F. C., & Malaysia, U. S. (2021) · Journal of Sustainability Science and Management · doi:10.46754/jssm.2021.10.020
The accelerated testing of cements in brines
Krumhansl, J. L. (1993) · University of North Texas Digital Library (University of North Texas)
COVID-19, Wide Spread and Treatment Need
El‐Shafey, E. S., & Elsherbiny, E. S. (2022) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2021.51022.1086
THE ROLE OF HYDROXYCHLOROQUINE IN THE TREATMENT OF HIV AND COVID-19: A REVIEW.
(2020) · International Journal of Engineering Sciences & Research Technology · doi:10.29121/ijesrt.v9.i7.2020.3
The Chemical Sciences' Advances on Coronavirus Disease 2019 (COVID-19)
Mondal, S. (2020) · Asian Journal of Organic & Medicinal Chemistry · doi:10.14233/ajomc.2020.ajomc-p286
Lem, F. F., Lee, D. J. H., Chee, F. T., Chin, S. N., Lin, K. M., & Yew, C.-W. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-rpm1s
Efficacies of repurposing chloroquine analogues for the treatment of COVID-19: Facts and mythsPreprint
Al‐Bari, M. A. A. (2020) · doi:10.22541/au.158679942.29108396
UPDATE SOBRE OS CUIDADOS PALIATIVOS NO CONTEXTO DA COVID-19
UNICEPLAC, C. U. D. P. C. A. D. S. –., QUEIROZ, E. C. D., Carvalho, V. P., Mendonça, A. B. L., Moreira, B. C., Kuster, B. P., SANTOS, E. C. A. D., Pagnoca, É. V. R. G., MOREIRA, F. B. D. S., Ribeiro, H. L. S., et al. (2022) · Editora UNINGÁ eBooks · doi:10.46311/978-65-991603-9-4
Singh, R., Bothra, N., Challa, M. M., & Kandra, P. (2022) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2022.12.1.l55-71
Metoprolol‘s Potential Beneficial Effects On Covid-19 Patients
Huyut, M. A., Alisha, G., Huyut, B. Ç., & Aliyeva, A. (2022) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.933801
COVID-19 Screening in Rheumatologic Diseases Cases; Special Look at Chloroquine Derivate Use
Shadmanfar, S., Alishiri, G. H., Bayat, N., Izadi, M., Salimzadeh, A., Rostamian, A., Abolghasemi, S., Ardebili, M. H. A., Moqaddam, Z. R., Hasani, M., et al. (2021) · Hospital Practices and Research · doi:10.34172/hpr.2021.27
Mao, H., Chu, C., Hu, X., & Yuan, Y. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.908
Current Updates on Covid-19 Vaccine Research and an Overview of Therapeutic Drug Research
Oviyaasri, O., Manjuladevi, M., Kalaiselvan, S., & Haripriyan, U. (2021) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2930
Screening of Anticancer Drugs as Potential Candidates to Target COVID-19 DiseasePreprint
Gurjar, G. S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12277046
COVID 19 opciones terapeuticas desde la viro-patogenesis a la evidencia clinica
González, J., & González, A. (2020) · Revista Colombiana de Nefrología · doi:10.22265/acnef.7.supl2.433
Swargiary, A., Verma, A. K., Daimari, M., & Roy, M. K. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12980306
Recomendaciones del Grupo interdisciplinario intersociedades científicas e intercátedras de Uruguay
(2020) · Revista Médica del Uruguay · doi:10.29193/rmu.36.1.12
Insights Into Challenges in Coronavirus Disease 2019 in Pediatrics
Elshorbagy, H. H., Omari, F. K. A., Ghashmari, H. M. A., & Barseem, N. F. (2020) · Clinical Infection and Immunity · doi:10.14740/cii103
A perspective Study on oral-fecal transmission of COVID-19, its Prevention and ManagementPreprint
Abdullah, A. (2020) · doi:10.31219/osf.io/r79v6
Swargiary, A., Verma, A. K., Daimari, M., & Roy, M. K. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12980306.v1
Are herbal drugs effective in COVID management? A review to demystify the current facts and claimsPreprint
Beg, M. R., Siddiqui, B., Waghmare, P., Ghodinde, S., & Bikkad, S. (2020) · doi:10.14293/s2199-1006.1.sor-.ppxfif7.v1
Pertuz, S. P. I., Aroca, G., Velez-Verbel, M. D., Osorio, A. G. C., Cadena-Bonfanti, A., Correa-Monterrosa, M., Castro, J. L., Brochado, L., Armesto, W., Vasquez, T. C., et al. (2020) · Revista Colombiana de Nefrología · doi:10.22265/acnef.7.supl2.420
A narrative review of newly approved drugs for COVID-19Preprint
Seetharaman, R., & Lokhande, J. (2020) · doi:10.31219/osf.io/7f3qs
Screening and Druggability Analysis of Some Plant Metabolites Against SARS-CoV-2Preprint
Azim, K. F., Ahmed, S. R., Banik, A., Khan, M. M. R., & Deb, A. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12235949
Tópicos em Ciências da Saúde – Volume 21
Pacheco, T. J. A., Souza, D. G. D., Faria, R. S., & Andrade, L. R. D. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8
Esen, A. D., Arica, S. G., & Şimşek, F. (2022) · Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi · doi:10.34087/cbusbed.984714
Vasilev, A. A., Grozdanov, P., Nikolova, I., Lozanov, V. S., & Kandinska, M. I. (2022) · Molbank · doi:10.3390/m1400
COVID-19: Origin, epidemiology, virology, pathogenesis, and treatment
Sharma, A., Ahirwar, A. K., Sorte, S. R., & Rathod, S. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99878-9.00012-1
On Physical Analysis of Some Topological Indices for Hydroxychloroquine and Chloroquine
Ojbag, J., & Ilmakchi, M. (2022) · Polycyclic aromatic compounds · doi:10.1080/10406638.2022.2092874
Gousiadou, C., & Sarimveis, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1909128/v1
حوكا, ب. أ. (2020) · Rowaq Arabi - رواق عربي · doi:10.53833/qalj5044
Neurological changes post-covid-19 infection
TOLEDO, J. P. F. E. D., Ferreira, L. A., de Souza, L. A., Cavalcante, F. R. P., Rebucci, R. C. S., da Silva, M. T. T., Santos, M. M., dos Santos, R. R. C., de Souza, H. G. P., Guimaraes, I. P. P., et al. (2022) · International Journal for Innovation Education and Research · doi:10.31686/ijier.vol10.iss9.3914
Ivermectin for Treatment of COVID-19?
Salama, H. A. E.-S. A., El‐Shayeb, M., Hassan, A. N. E.-D., Amin, G. E. E.-D., Allam, M. F., & Ahmed, E. E.-S. (2022) · Trends journal of sciences research · doi:10.31586/wjmm.2022.474
Patel, D. K., Piparva, K. G., & Singh, A. P. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/0400207
Krūmiņa-Koņkova, S. (2022) · Reliģiski-filozofiski raksti · doi:10.22364/rfr.32
Metadata
- Authors
- Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D.
- Affiliations
- Aix-Marseille Université (FR)
- Corresponding author
- Raoult, Didier
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 55
- Issue
- 4
- Pages
- 105932
- ISSN
- 0924-8579 (ISSN-L)
- PMC
- PMC7135139
- OpenAlex
- W3010277308
- Cited by
- 937
- References
- 26
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 21 · 2023: 45 · 2022: 71 · 2021: 215 · 2020: 564
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- International Journal of Antimicrobial Agents (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IAHU-0003)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Keywords
- chloroquine, hydroxychloroquine, COVID-19 pandemic, SARS-CoV-2, antimalarial drugs, antiviral therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adenosine Monophosphate, Alanine, Chloroquine, Hydroxychloroquine, Pneumonia, Viral, Coronavirus, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review